A randomized,double-blind,multicenter,Phase2,three-arm,placebo-control study of apatinib as third line treatment in patients with metastatic gastric carcinoma
Jin Li Nong Xu Ying Cheng Zhehai Wang Leizhen Zheng Min Tao xiaodong Zhu Dongmei Ji Xin Liu Shukui Qin Jianming Xu weijian Guo Jianping Xiong Yuxian Bai Guoping Sun Yan Yang Liwei Wang
200032 复旦大学附属肿瘤医院肿瘤内科 南京八一医院肿瘤中心 北京307医院消化内科
国内会议
北京
英文
45-46
2012-09-19(万方平台首次上网日期,不代表论文的发表时间)